Add BrightSurf on Google Email

Boston University School of Medicine


Marketing, prescribing testosterone and growth hormone for aging is disease mongering

The marketing, prescribing, and selling of testosterone and growth hormone as solutions for aging-associated problems is considered disease mongering. The FDA has recently acknowledged that these treatments are not indicated for age-related decline in serum testosterone, with potential risks outweighing benefits.

SourceBoston University School of Medicine·JournalJournal of the American Geriatrics Society·DateMar 24, 2015

Study finds hormone therapy in transgender adults safe

A comprehensive review of hormone therapy in transgender adults has found no significant increase in cancer risk despite previous concerns. The study, published in the Journal of Clinical and Translational Endocrinology, provides reassurance for individuals requiring hormone treatments, reducing anxiety and increasing access to care.

SourceBoston University School of Medicine·JournalJournal of Clinical & Translational Endocrinology·DateFeb 24, 2015

BU study finds occupational link in kidney disease epidemic in Central America

A new BU study finds a decline in kidney function among Nicaraguan sugarcane workers, suggesting heat stress and dehydration may play a role in the high rates of chronic kidney disease. The research team recruited 284 workers performing different tasks and found that those with longer employment duration had worse kidney function.

SourceBoston University School of Medicine·JournalInternational Archives of Occupational and Environmental Health·DateFeb 2, 2015

Cell-associated HIV mucosal transmission: The neglected pathway

Researchers from Boston University School of Medicine propose that cell-associated HIV transmission is an important element contributing to the HIV epidemic, challenging traditional views on virus transmission. Genetic evidence suggests that HIV-infected cells populate genital secretions and breast milk, providing a new target for HIV ...

SourceBoston University School of Medicine·JournalThe Journal of Infectious Diseases·DateDec 18, 2014

In-utero methadone, subutex exposure could alter gene expression, cause severe neonatal abstience syndrome

Researchers found that infants exposed to opioids in utero had more severe symptoms of neonatal abstinence syndrome, with higher DNA methylation levels. This study suggests a link between early exposure and lasting epigenetic changes, potentially affecting future sensitivity to addictive substances.

SourceBoston University School of Medicine·JournalThe Journal of Pediatrics·DateAug 19, 2014